Impact Of Gender And Age In The Very Long Term Clinical Outcomes Of Consecutive, Non-selected, Real-world Patients: Insights From The Desire Registry

被引:0
|
作者
Costa, Jose de Ribamar, Jr. [1 ]
Sousa, Amanda [1 ]
Moreira, Adriana [1 ]
Costa, Ricardo [1 ]
Maldonado, Galo [1 ]
Cano, Manuel [1 ]
Campos, Cantidio [1 ]
Carballo, Mariana [1 ]
Pavanello, Ricardo [1 ]
Sousa, J. Eduardo [1 ]
机构
[1] Hosp Coracao, Sao Paulo, Brazil
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2009年 / 104卷 / 6A期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:208D / 209D
页数:2
相关论文
共 50 条
  • [41] LONG TERM CLINICAL OUTCOMES FROM USE OF SIROLIMUS COATED BALLOON IN CORONARY INTERVENTION; DATA FROM A REAL-WORLD POPULATION
    Waduge, Bhagya Harindi Loku
    Kalkat, Harkaran
    Fawzy, Ameenathul Mazaya
    Saif, Abdullah
    Athukorala, Sampath
    Bhatia, Gurbir
    Kumar, Nitin
    Freestone, Bethan
    Ment, Jerome
    Lee, Kaeng
    Pitt, Michael
    Pulikal, George
    Basavarajaiah, Sandeep Basavarajaiah Sandeep
    HEART, 2021, 107 : A47 - A47
  • [42] Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease
    Shin, Ho Sik
    Kil, Song Yi
    Park, Byung Hwa
    Kim, Ye Na
    Jung, Yeonsoon
    Rim, Hark
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I924 - I924
  • [43] Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease
    Im, S. I.
    Shin, H. S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [44] Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease
    Shin, Ho Sik
    Kil, Song Yi
    Park, Byung Hwa
    Kim, Ye Na
    Jung, Yeonsoon
    Rim, Hark
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [45] Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device
    Parikh, Valay
    Bartus, Krzysztof
    Litwinowicz, Radoslaw
    Turagam, Mohit K.
    Sadowski, Jerzy
    Kapelak, Boguslaw
    Bartus, Magdalena
    Podolec, Jakub
    Brzezinski, Maciej
    Musat, Dan
    Rasekh, Abdi
    Mittal, Suneet
    Cheng, Jie
    Badhwar, Nitish
    Lee, Randall
    Lakkireddy, Dhanunjaya
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2019, 30 (12) : 2849 - 2857
  • [46] Long-Term clinical efficacy of liraglutide for type 2 diabetes: real-world evidence and outcomes from Pakistan
    Butt, Muhammad Daoud
    Ong, Siew Chin
    Rafiq, Azra
    Batool, Nighat
    Saifi, Rumana
    Yaseen, Samina
    Kaukab, Irum
    Ramzan, Basit
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [47] Long-term trends in the clinical outcomes of patients with acute myeloid leukemia: a population-based real-world data analysis using the Osaka Cancer Registry
    Shigeo Fuji
    Shuhei Kida
    Kayo Nakata
    Toshitaka Morishima
    Isao Miyashiro
    Jun Ishikawa
    Annals of Hematology, 2021, 100 : 2717 - 2725
  • [48] Long-term trends in the clinical outcomes of patients with acute myeloid leukemia: a population-based real-world data analysis using the Osaka Cancer Registry
    Fuji, Shigeo
    Kida, Shuhei
    Nakata, Kayo
    Morishima, Toshitaka
    Miyashiro, Isao
    Ishikawa, Jun
    ANNALS OF HEMATOLOGY, 2021, 100 (11) : 2717 - 2725
  • [49] Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry
    Nabi, Hafsah
    Hendricks, Oliver
    Jensen, Dorte Vendelbo
    Loft, Anne Gitte
    Pedersen, Jens Kristian
    Just, Soren Andreas
    Danebod, Kamilla
    Munk, Heidi Lausten
    Kristensen, Salome
    Manilo, Natalia
    Colic, Ada
    Linauskas, Asta
    Thygesen, Pia Hoger
    Christensen, Louise Brot
    Kalisz, Maren Hogberget
    Lomborg, Niels
    Chrysidis, Stavros
    Raun, Johnny Lillelund
    Andersen, Marlene
    Mehnert, Frank
    Krogh, Niels Steen
    Hetland, Merete Lund
    Glintborg, Bente
    RMD OPEN, 2022, 8 (02):
  • [50] INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY
    Nabi, H.
    Hetland, M. L.
    Loft, A. G.
    Hendricks, O.
    Jensen, D.
    Pedersen, J. K.
    Just, S. A.
    Danebod, K.
    Munk, H. L.
    Kristensen, S.
    Manilo, N.
    Colic, A.
    Linauskas, A.
    Thygesen, P. H.
    Christensen, L. B.
    Kalisz, M. Hogberget
    Lomborg, N.
    Grydehoj, J.
    Raun, J.
    Ahmed, R.
    Mehnert, F.
    Krogh, N. Steen
    Glintborg, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 45 - 46